The general methyl transferase inhibitor DZNep, and three different EZH2 inhibitors, GSK126, GSK343, and tazemetostat (TAZ), collectively appointed as EZH2i, were used to treat two different ACC cell models: H295R and MUC-1. The gene discussed is MUC1; the disease is adrenal cortex carcinoma.